These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9619690)

  • 21. Neuroendocrine predictors of response to intravenous clomipramine therapy for refractory obsessive-compulsive disorder.
    Mathew SJ; Coplan JD; Perko KA; Goetz RR; de la Neuz M; Hollander E; Liebowitz MR; Fallon BA
    Depress Anxiety; 2001; 14(4):199-208. PubMed ID: 11754126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravenous clomipramine challenge in obsessive-compulsive disorder: predicting response to oral therapy at eight weeks.
    Sallee FR; Koran LM; Pallanti S; Carson SW; Sethuraman G
    Biol Psychiatry; 1998 Aug; 44(3):220-7. PubMed ID: 9693393
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of comorbid body dysmorphic disorder on the response to sequential pharmacological trials for obsessive-compulsive disorder.
    Diniz JB; Costa DL; Cassab RC; Pereira CA; Miguel EC; Shavitt RG
    J Psychopharmacol; 2014 Jun; 28(6):603-11. PubMed ID: 24288238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clomipramine in obsessive-compulsive disorder.
    Katz RJ; DeVeaugh-Geiss J; Landau P
    Biol Psychiatry; 1990 Sep; 28(5):401-14. PubMed ID: 2207219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of drug treatment in obsessive-compulsive disorder. A meta-analytic review.
    Piccinelli M; Pini S; Bellantuono C; Wilkinson G
    Br J Psychiatry; 1995 Apr; 166(4):424-43. PubMed ID: 7795913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Open trial of intravenous clomipramine in five treatment-refractory patients with obsessive-compulsive disorder.
    Fallon BA; Campeas R; Schneier FR; Hollander E; Feerick J; Hatterer J; Goetz D; Davies S; Liebowitz MR
    J Neuropsychiatry Clin Neurosci; 1992; 4(1):70-5. PubMed ID: 1627966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous anti-obsessive agents: a review.
    Ravindran LN; Jung SM; Ravindran AV
    J Psychopharmacol; 2010 Mar; 24(3):287-96. PubMed ID: 18801828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Understanding the response lag to tricyclics. I. Application of pulse-loading regimens with intravenous clomipramine.
    Pollock BG; Perel JM; Shostak M; Antelman SM; Brandom B; Kupfer DJ
    Psychopharmacol Bull; 1986; 22(1):214-9. PubMed ID: 3726069
    [No Abstract]   [Full Text] [Related]  

  • 29. A case report of refractory obsessive-compulsive disorder improved by risperidone augmentation of clomipramine treatment.
    Kawahara T; Ueda Y; Mitsuyama Y
    Psychiatry Clin Neurosci; 2000 Oct; 54(5):599-601. PubMed ID: 11043813
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of acute intravenous clomipramine on obsessive-compulsive symptoms and response to chronic treatment.
    Mundo E; Bellodi L; Smeraldi E
    Biol Psychiatry; 1995 Oct; 38(8):525-31. PubMed ID: 8562664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical features associated with treatment response in obsessive-compulsive disorder.
    Shavitt RG; Belotto C; Curi M; Hounie AG; Rosário-Campos MC; Diniz JB; Ferrão YA; Pato MT; Miguel EC
    Compr Psychiatry; 2006; 47(4):276-81. PubMed ID: 16769302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Standard criteria for relapse are needed in obsessive-compulsive disorder.
    Simpson HB; Franklin ME; Cheng J; Foa EB; Liebowitz MR
    Depress Anxiety; 2005; 21(1):1-8. PubMed ID: 15806597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of compulsive sexual behaviour with clomipramine and valproic acid.
    Gulsun M; Gulcat Z; Aydin H
    Clin Drug Investig; 2007; 27(3):219-23. PubMed ID: 17305416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aggravation of schizophrenia by clomipramine in a patient with comorbid obsessive-compulsive disorder.
    Margetić B; Aukst-Margetić B; Jakovljević M
    Psychopharmacol Bull; 2008; 41(2):9-11. PubMed ID: 18668013
    [No Abstract]   [Full Text] [Related]  

  • 35. [Pharmacotherapy of compulsive disorders in childhood and adolescence].
    Wewetzer Ch; Mehler-Wex C; Warnke A
    Z Kinder Jugendpsychiatr Psychother; 2003 Aug; 31(3):223-30. PubMed ID: 12942794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clomipramine treatment of childhood obsessive-compulsive disorder. A double-blind controlled study.
    Flament MF; Rapoport JL; Berg CJ; Sceery W; Kilts C; Mellström B; Linnoila M
    Arch Gen Psychiatry; 1985 Oct; 42(10):977-83. PubMed ID: 3899048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.
    Freeman CP; Trimble MR; Deakin JF; Stokes TM; Ashford JJ
    J Clin Psychiatry; 1994 Jul; 55(7):301-5. PubMed ID: 8071291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clomipramine and obsessive-compulsive disorder.
    Scahill L; Lynch KA
    J Child Adolesc Psychiatr Nurs; 1995; 8(2):42-5. PubMed ID: 7795952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of adolescent obsessive-compulsive disorder with a clomipramine-fluoxetine combination.
    Simeon JG; Thatte S; Wiggins D
    Psychopharmacol Bull; 1990; 26(3):285-90. PubMed ID: 2274627
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A double-blind comparison of sertraline and clomipramine in outpatients with obsessive-compulsive disorder.
    Bisserbe J; Lane R; Flament M;
    Eur Psychiatry; 1997; 12(2):82-93. PubMed ID: 19698511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.